New Drugs of 2022 – Pharmacist, Nurse, Nurse Practitioner

  Price  $10.00

  Credits  2

Clear


Format

In 2022, the U.S. Food and Drug Administration (FDA) approved 30 novel drugs , 27 of which were the first in their class. This issue of The Rx Consultant focuses on new drugs approved in 2022 that may be important additions to the treatment of conditions commonly seen by community practitioners. Select new drugs are discussed in detail throughout the issue, including indication, a summary of evidence used to approve the drug, safety, efficacy, and important patient information.

$10.00

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharmacist

Nurse Practitioner

Nurse

Author

Golden L. Peters
PharmD, BCPS
Erin Raney
PharmD, BCPS, BC-ADM, FCCP
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Pharmacist

Pharmacist

  • Identify brand/generic names, indication(s), dose, interactions, adverse reactions, precautions, and contraindications for newly approved drugs reviewed in detail
  • Recall the efficacy and safety outcomes of studies for newly approved drugs reviewed in detail
  • Identify patient counseling points for newly approved drugs reviewed in detail
  • Recognize brand/generic names, indications, and mechanism of action of newly approved drugs briefly summarized in Table 2

Nurse Practitioner

Nurse Practitioner

  • Identify brand/generic names, indication(s), dose, interactions, adverse reactions, precautions, and contraindications for newly approved drugs reviewed in detail
  • Recall the efficacy and safety outcomes of studies for newly approved drugs reviewed in detail
  • Identify patient counseling points for newly approved drugs reviewed in detail
  • Recognize brand/generic names, indications, and mechanism of action of newly approved drugs briefly summarized in Table 2

Nurse

Nurse

  • Identify brand/generic names, indication(s), dose, interactions, adverse reactions, precautions, and contraindications for newly approved drugs reviewed in detail
  • Recall the efficacy and safety outcomes of studies for newly approved drugs reviewed in detail
  • Identify patient counseling points for newly approved drugs reviewed in detail
  • Recognize brand/generic names, indications, and mechanism of action of newly approved drugs briefly summarized in Table 2

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    20-999890
  • Universal Activity Number:
    Nurse : 0798-0000-23-038-H01-N
    Pharmacist : 0798-0000-23-038-H01-P
    Nurse Practitioner : 0798-0000-23-038-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.